Zou, F., Lu, L., Liu, J., Xia, B., Zhang, W., Hu, Q., . . . Zhang, H. (2019). Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nature Portfolio.
Chicago Style (17th ed.) CitationZou, Fan, et al. Engineered Triple Inhibitory Receptor Resistance Improves Anti-tumor CAR-T Cell Performance via CD56. Nature Portfolio, 2019.
MLA (8th ed.) CitationZou, Fan, et al. Engineered Triple Inhibitory Receptor Resistance Improves Anti-tumor CAR-T Cell Performance via CD56. Nature Portfolio, 2019.
Warning: These citations may not always be 100% accurate.